AP
STIM icon

Atwood & Palmer’s Neuronetics STIM Stock Holding History

Atwood & Palmer’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-100
Closed -$349 – 529
2025
Q2 		$349 Hold
100
– – ﹤0.01% 499
2025
Q1 		$368 Hold
100
– – ﹤0.01% 427
2024
Q4 		$161 Hold
100
– – ﹤0.01% 459
2024
Q3 		$76 Hold
100
– – ﹤0.01% 467
2024
Q2 		$180 Hold
100
– – ﹤0.01% 424
2024
Q1 		$476 Hold
100
– – ﹤0.01% 400
2023
Q4 		$290 Hold
100
– – ﹤0.01% 392
2023
Q3 		$135 Hold
100
– – ﹤0.01% 401
2023
Q2 		$215 Hold
100
– – ﹤0.01% 387
2023
Q1 		$291 Hold
100
– – ﹤0.01% 361
2022
Q4 		$687 Hold
100
– – ﹤0.01% 376
2022
Q3 		$0 Hold
100
– – ﹤0.01% 400
2022
Q2 		$0 Buy
+100
New +$290 ﹤0.01% 440

Other funds holding STIM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Atwood & Palmer's STIM Position: Q3 2025 in Review

Atwood & Palmer sold out of Neuronetics (STIM) in Q3 2025, closing a stake of 100 shares — an estimated $349 sold.

Atwood & Palmer first reported a position in STIM in Q2 2022 and held it in 13 quarters. The position peaked at $687 in Q4 2022. 99 funds tracked by Wall St. Rank hold STIM as of Q3 2025.

  • Atwood & Palmer reported no remaining Neuronetics position as of Q3 2025 after selling out during the quarter.
  • Atwood & Palmer sold 100 Neuronetics shares in Q3 2025, an estimated $349.
  • Atwood & Palmer first reported a position in Neuronetics in Q2 2022 and held it in 13 quarters.
  • Atwood & Palmer's Neuronetics position peaked at $687 in Q4 2022.
  • 99 funds tracked by Wall St. Rank held Neuronetics as of Q3 2025.

Based on Atwood & Palmer's 13F filing for Q3 2025, filed 15 Oct 2025.